James Mojirade 4
4 · AVANOS MEDICAL, INC. · Filed Mar 7, 2023
Insider Transaction Report
Form 4
James Mojirade
SVP, General Counsel
Transactions
- Award
Common Stock
2023-03-06+20,339→ 47,217 total - Tax Payment
Common Stock
2023-03-06$29.62/sh−2,111$62,528→ 45,106 total
Footnotes (2)
- [F1]Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 6, 2024, 1/3 on March 6, 2025 and 1/3 on March 6, 2026.
- [F2]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of time-based restricted share units awarded to the Reporting Person on March 4, 2022, 1/3 of which vested on March 4, 2023, with the remainder vesting 1/3 on March 4, 2024 and 1/3 on March 4, 2025.